Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hartkopf

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Archives of Gynecology and Obstetrics|August 13, 2011
Differential mRNA expression of TACR1 after ischemic peritoneal trauma: a pilot animal studyBernhard Kraemer, Markus Wallwiener, Christian W Wallwiener, et al.
Archives of Gynecology and Obstetrics|January 4, 2020
Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literatureMalgorzata Banys-Paluchowski, Ines Verena Gruber, Andreas Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2026
Feasibility of <i>PIK3CA</i> Mutation Detection via Microfluidic Isolation of Disseminated Tumor Cells from Bone Marrow in Breast Cancer PatientsHanne Grollmann, Barbara Volz, Werner Schroth, et al.
Clinical Breast Cancer|November 13, 2025
Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort AnalysisJannik Daniel Kandzi, Alexander Englisch, Bettina Boeer, et al.
BMC Cancer|July 6, 2013
Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancerInes V Gruber, Miriam Rueckert, Karl O Kagan, et al.
JMIR Cancer|October 12, 2021
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort StudyKatharina Brusniak, Manuel Feisst, Linda Sebesteny, et al.
Archives of Gynecology and Obstetrics|February 19, 2021
Fertility preserving management of early endometrial cancer in a patient cohort at the department of women's health at the university of TuebingenJürgen Andress, Jana Pasternak, Christina Walter, et al.
Archives of Gynecology and Obstetrics|April 25, 2022
How previous treatment changes the metabolomic profile in patients with metastatic breast cancerJuliane Nees, Simon Schafferer, Baowen Yuan, et al.
Anticancer Research|June 4, 2021
The SOX2 Status of Disseminated Tumor Cells in Breast Cancer Patients Treated With Neoadjuvant ChemotherapyNatalia Krawczyk, Kathrin Janowski, Maggie Banys-Paluchowski, et al.
BMC Cancer|June 5, 2014
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patientsNatalia Krawczyk, Andreas Hartkopf, Malgorzata Banys, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Archives of Gynecology and Obstetrics|August 13, 2011
Differential mRNA expression of TACR1 after ischemic peritoneal trauma: a pilot animal studyBernhard Kraemer, Markus Wallwiener, Christian W Wallwiener, et al.
Archives of Gynecology and Obstetrics|January 4, 2020
Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literatureMalgorzata Banys-Paluchowski, Ines Verena Gruber, Andreas Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2026
Feasibility of <i>PIK3CA</i> Mutation Detection via Microfluidic Isolation of Disseminated Tumor Cells from Bone Marrow in Breast Cancer PatientsHanne Grollmann, Barbara Volz, Werner Schroth, et al.
Clinical Breast Cancer|November 13, 2025
Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort AnalysisJannik Daniel Kandzi, Alexander Englisch, Bettina Boeer, et al.
BMC Cancer|July 6, 2013
Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancerInes V Gruber, Miriam Rueckert, Karl O Kagan, et al.
JMIR Cancer|October 12, 2021
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort StudyKatharina Brusniak, Manuel Feisst, Linda Sebesteny, et al.
Archives of Gynecology and Obstetrics|February 19, 2021
Fertility preserving management of early endometrial cancer in a patient cohort at the department of women's health at the university of TuebingenJürgen Andress, Jana Pasternak, Christina Walter, et al.
Archives of Gynecology and Obstetrics|April 25, 2022
How previous treatment changes the metabolomic profile in patients with metastatic breast cancerJuliane Nees, Simon Schafferer, Baowen Yuan, et al.
Anticancer Research|June 4, 2021
The SOX2 Status of Disseminated Tumor Cells in Breast Cancer Patients Treated With Neoadjuvant ChemotherapyNatalia Krawczyk, Kathrin Janowski, Maggie Banys-Paluchowski, et al.
BMC Cancer|June 5, 2014
Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patientsNatalia Krawczyk, Andreas Hartkopf, Malgorzata Banys, et al.
Pageof 9